Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity
Open Access
- 11 November 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 89 (10), 1971-1978
- https://doi.org/10.1038/sj.bjc.6601370
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Breast Cancer Resistance Protein (BCRP/ABCG2) Induces Cellular Resistance to HIV-1 Nucleoside Reverse Transcriptase InhibitorsMolecular Pharmacology, 2003
- Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance.2002
- A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistance.2002
- Estrone and 17β‐Estradiol Reverse Breast Cancer Resistance Protein‐mediated Multidrug ResistanceJapanese Journal of Cancer Research, 2002
- The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.2002
- In vitro characterization of hepatic flavopiridol metabolism using human liver microsomes and recombinant UGT enzymes.Pharmaceutical Research, 2002
- Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer CellsBiochemical and Biophysical Research Communications, 2001
- Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.International Journal of Oncology, 2000
- Multidrug-resistant Human Sarcoma Cells with a Mutant P-Glycoprotein, Altered Phenotype, and Resistance to CyclosporinsPublished by Elsevier BV ,1997
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990